Pixels & Pills

Paul Roellig of BulletinNEWS on the FDA and Publishing

November 20th, 2009 · No Comments · News

Google Buzz

Paul Roellig, CEO of BulletinNEWS explains how restrictions on advertising and social media by the FDA could impact the medical publishing business and cut off valuable sources of information for healthcare professionals.

  • Share/Bookmark

Tags: ···················

No Comments so far ↓

There are no comments yet...Kick things off by filling out the form below.

Leave a Comment